Bipartisan lawmakers reintroduce sanctions legislation targeting Chinese entities linked to fentanyl precursor trafficking.

Quiver AI Summary

Lawmakers reintroduce bill on fentanyl: Reps. Jake Auchincloss, Dan Newhouse, John Moolenaar and Ro Khanna said they reintroduced the “CCP Fentanyl Sanctions Act,” aimed at expanding sanctions on China-based and CCP-backed entities they say are involved in fentanyl trafficking.

Measure details and claims: The release says the bill would build on Executive Order 14059 and add authorities targeting Chinese chemical manufacturers, online vendors, vessels, ports and financial institutions that “knowingly or recklessly” facilitate synthetic narcotics shipments or sales.

Lawmakers’ comments: The members said the proposal is intended to address the fentanyl crisis and hold responsible parties accountable. They cited a 2024 House Select Committee working group report and said the legislation is a bipartisan effort to curb the flow of fentanyl precursors into the U.S.

Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.

Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.

Jake Auchincloss Fundraising

Jake Auchincloss Fundraising

Jake Auchincloss recently disclosed $138.6K of fundraising in a Pre-Primary FEC disclosure filed on August 20th, 2026. This was the 299th most from all Pre-Primary reports we have seen this year. 58.5% came from individual donors.

Auchincloss disclosed $161.8K of spending. This was the 474th most from all Pre-Primary reports we have seen from politicians so far this year.

Auchincloss disclosed $7.3M of cash on hand at the end of the filing period. This was the 15th most from all Pre-Primary reports we have seen this year.

See also  MDB Capital Holdings Q2 2026 Update: Results, Outlook, Risks

You can see the disclosure here, or track Jake Auchincloss’s fundraising on Quiver Quantitative.

Jake Auchincloss Net Worth

Quiver Quantitative estimates that Jake Auchincloss is worth $4.5M, as of August 24th, 2026. This is the 179th highest net worth in Congress, per our live estimates.

Auchincloss has approximately $2.0M invested in publicly traded assets which Quiver is able to track live.

You can track Jake Auchincloss’s net worth on Quiver Quantitative’s politician page for Auchincloss.

Jake Auchincloss Bill Proposals

Here are some bills which have recently been proposed by Jake Auchincloss:

  • H.R.9823: Alzheimer’s Early Detection Act of 2026
  • H.R.7568: Hot Rock Act
  • H.R.6837: To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes.
  • H.R.6610: Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act]
  • H.R.6609: Pharmacists Fight Back in Medicare and Medicaid Act
  • H.R.6335: Education Not Endless Scrolling Act

You can track bills proposed by Jake Auchincloss on Quiver Quantitative’s politician page for Auchincloss.

2026 Massachusetts’s 4th Congressional District Election

There has been approximately $4,545,698 of spending in Massachusetts’s 4th congressional district elections over the last two years, per our estimates.

Approximately $170,705 of this has been from outside spending by PACs and Super PACs. Some of the groups who are spending money in this race include:

The rating for this race is currently “Solid D”.

You can track this election on our matchup page for the 2026 Massachusetts’s 4th congressional district election.


Source link

See also  A Lumentum Executive Sold 2,000 Shares Under a Plan He Filed in May. Here's What to Know

Author

Shin John
Shin JohnYtv Market News
Share-market news writer and analyst with deep experience covering equities, commodities, forex, and cryptocurrencies for readers in the USA, UK, Canada, and Australia. Ytv Market News delivers timely market updates, practical trading insights, and clear explanations of macro and company-level catalysts that move prices. Combines on-the-ground financial reporting with technical analysis, using concise charts and actionable ideas to help investors and traders make smarter decisions.